Author Details
MRP:
₹520*
₹504.4*
MRP ₹520
3% CB
₹15.6 cashback(3%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
Available Offers
APLICICISave 19% on medicine orders above Rs. 1999 with ICICI credit Card
ONECARD5Flat 5% off on non- medicine orders above Rs. 700 with OneCard
ONECARD18Flat 18% Off on medicine orders above Rs. 1250 with OneCard
APOLLOMOBIKWIKUpto Rs. 500 cashback on payments above Rs. 999 with Mobikwik Wallet
APLAZYPAYUpto Rs. 300 cashback on 1st transaction of Rs. 500 and above with LazyPay
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Composition :
CLINDAMYCIN-1%W/V
Manufacturer/Marketer :
Alkem Laboratories Ltd
Consume Type :
TOPICAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Clindac A 1% Mist Spray Substitute
Erytop 1% Mist Spray 100 ml
by Others
₹4.95per tabletClinmiskin Mist Spray 100 ml
by Others
₹4.95per tabletErytop Mist Spray
by Others
₹0.42per tabletAceclin Mist Spray
by Others
₹4.05per tablet
Product Substitutes
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
56 people bought in last 7 days
coupon
coupon
Drug-Diseases Interactions
CLINDAMYCIN-1%W/VOther bacterial intestinal infections
Severe
CLINDAMYCIN-1%W/VDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
Drug-Diseases Interactions
Login/Sign Up
CLINDAMYCIN-1%W/VOther bacterial intestinal infections
Severe
How does the disease interact with Clindac A 1% Mist Spray 100 ml:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
CLINDAMYCIN-1%W/VDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
How does the disease interact with Clindac A 1% Mist Spray 100 ml:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
CLINDAMYCIN-1%W/VOther diseases of liver
Moderate
How does the disease interact with Clindac A 1% Mist Spray 100 ml:
The liver is the primary site of Clindac A 1% Mist Spray 100 ml metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindac A 1% Mist Spray 100 ml and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindac A 1% Mist Spray 100 ml therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Clindac A 1% Mist Spray 100 ml is primarily metabolized by the liver. Therapy with Clindac A 1% Mist Spray 100 ml should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
The liver is the primary site of Clindac A 1% Mist Spray 100 ml metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindac A 1% Mist Spray 100 ml and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindac A 1% Mist Spray 100 ml therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Clindac A 1% Mist Spray 100 ml is primarily metabolized by the liver. Therapy with Clindac A 1% Mist Spray 100 ml should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/VOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clindac A 1% Mist Spray 100 ml:
Clindac A 1% Mist Spray 100 ml is partially removed by the kidney. Clindac A 1% Mist Spray 100 ml should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindac A 1% Mist Spray 100 ml should be administered cautiously in patients with severely impaired renal function. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Clindac A 1% Mist Spray 100 ml is partially removed by the kidney. Clindac A 1% Mist Spray 100 ml should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindac A 1% Mist Spray 100 ml should be administered cautiously in patients with severely impaired renal function. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/VOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clindac A 1% Mist Spray 100 ml:
Clindac A 1% Mist Spray 100 ml is partially removed by the kidney. Clindac A 1% Mist Spray 100 ml should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindac A 1% Mist Spray 100 ml should be administered cautiously in patients with severely impaired renal function. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Clindac A 1% Mist Spray 100 ml is partially removed by the kidney. Clindac A 1% Mist Spray 100 ml should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindac A 1% Mist Spray 100 ml should be administered cautiously in patients with severely impaired renal function. Serum Clindac A 1% Mist Spray 100 ml concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
